SeekiNF
SEC filings at your fingertips in seconds with SeekiNF

HOME ABOUT US SeekiNF FRAANK FAQs CONTACT US LOGIN
Recent Press and Other Releases Search SeekiNF Examples

Click Here for

All Press Releases All Conference Calls All Shareholder Meetings

Recent Releases

October 20, 2017 17:29:35 ET

Clarus Corp (CIK: 913277)

EX-23.1tv477351_ex23-1.htmCONSENT OF INDEPENDENT AUDITORS Exhibit 23.1 CONSENT OF INDEPENDENT AUDITOR We consent to the incorporation by referencein the registration statement No. 333-218754 on Form S-8 of our report dated March 9, 2017, with respect to the consolidated balancesheets of Sierra Bullets, L.L.C. as of December 31, 2016 and 2015, and the related consolidated statements of income, changes inmembers’ equity and cas More »

October 20, 2017 17:29:35 ET

Clarus Corp (CIK: 913277)

EX-99.2tv477351_ex99-2.htmAUDITED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.2 SIERRABULLETS, LLC AND AFFILIATECONSOLIDATED FINANCIAL STATEMENTSFOR THE YEARS ENDEDDECEMBER 31, 2016 and 2015    SIERRA BULLETS, LLC AND AFFILIATECONTENTSDecember 31, 2016 and 2015   Page  INDEPENDENT AUDITOR’S REPORT1 - 2  CONSOLIDATED FINANCIAL STATEMENTS   Consolidated Balance S More »

October 20, 2017 17:29:35 ET

Clarus Corp (CIK: 913277)

EX-99.3tv477351_ex99-3.htmUNAUDITED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.3 SIERRA BULLETS, LLC AND AFFILIATECONSOLIDATED FINANCIAL STATEMENTSAS OF JUNE 30, 2017 AND DECEMBER 31, 2016AND FOR THE SIX MONTHS ENDEDJUNE 30, 2017 AND 2016    SIERRA BULLETS, LLC AND AFFILIATECONTENTSAs of June 30, 2017 and December 31, 2016And for the Six Months Ended June 30,2017 and 2016   Page  INDEPENDEN More »

October 20, 2017 17:29:35 ET

Clarus Corp (CIK: 913277)

EX-99.4tv477351_ex99-4.htmUNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIALINFORMATION The unaudited pro forma condensed combinedfinancial information for the period indicated below shows the effect of Clarus Corporation’s (“Clarus,” the“Company,” “we,” or “our”), through Everest/Sapphire Acquisition, LLC ( More »

October 20, 2017 17:28:15 ET

Juno Therapeutics, Inc. (CIK: 1594864)

EX-10.1exhibit101.htmEXHIBIT 10.1ExhibitExhibit 10.1JUNO THERAPEUTICS, INC.2014 EQUITY INCENTIVE PLANRESTRICTED STOCK AGREEMENT NOTICE OF GRANT OF RESTRICTED STOCK Unless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Restricted Stock Agreement, including the Notice of Grant of Restricted Stock (the “Notice of Grant”), the Terms and Co More »

Contact Dr. Raj Srivastava at rsrivastava@seekedgar.com for full subscription and other details.